Karyopharm Therapeutics (KPTI) P/E (2013 - 2026)
Karyopharm Therapeutics (KPTI) P/E from Nov 6, 2013 to Jul 21, 2026. The TTM Karyopharm Therapeutics (KPTI) P/E is -0.54. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Karyopharm Therapeutics (KPTI)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.54 | +19.56% |
| 2025 | -0.45 | -58.31% |
| 2024 | -1.07 | +52.22% |
| 2023 | -0.71 | -77.74% |
| 2022 | -3.17 | -18.65% |
| 2021 | -3.90 | -32.78% |
| 2020 | -5.80 | -3.19% |
| 2019 | -5.99 | +96.73% |
| 2018 | -3.04 | -16.64% |
| 2017 | -3.65 | +18.08% |
| 2016 | -3.09 | -22.87% |
| 2015 | -4.01 | -93.23% |
| 2014 | -59.26 | +63.31% |
| 2013 | -36.29 | N/A |
Comparison Karyopharm Therapeutics (KPTI) P/E with competitors
Karyopharm Therapeutics (KPTI) P/E is -0.54.